trending Market Intelligence /marketintelligence/en/news-insights/trending/xxe2ppv6d64_2if3cuh_ya2 content esgSubNav
In This List

Apricus Biosciences commences common stock, warrants offering

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Apricus Biosciences commences common stock, warrants offering

Apricus Biosciences, Inc. said it began a public offering of its common shares and warrants to buy common stock.

The San Diego-based biopharmaceutical company plans to use the net proceeds for working capital and general corporate purposes.

H.C. Wainwright & Co. is acting as exclusive placement agent for the offering.